GlassScriptPhysician profile
Matthias Solga
NPI 1194063495
$6,203.27
in general payments reported to CMS, 2019-2025
28 companies · $1,410 in 2025
The $1,410 reported for 2025 was more than what a typical Urology provider received nationally (typical 2025 total: $631).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $663 · 2020: $794 · 2021: $816 · 2022: $760 · 2023: $864 · 2024: $897 · 2025: $1,410.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $2,726 · Education: $445.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $2,726.33 |
| Education | $444.98 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Astellas Pharma US INC | $1,640.97 | 2019-2025 | Xtandi |
| Antares Pharma, INC. | $1,596.83 | 2019-2025 | Xyosted, Tlando, Nocdurna |
| Sumitomo Pharma America, INC. | $418.17 | 2023-2025 | Gemtesa |
| Tolmar, INC. | $310.17 | 2023-2025 | Jatenzo, Eligard |
| Pfizer INC. | $266.16 | 2019-2025 | |
| Ferring Pharmaceuticals INC. | $214.76 | 2019-2025 | Adstiladrin |
| Abbvie INC. | $213.19 | 2019-2025 | Botox |
| Urovant Sciences INC | $187.47 | 2021-2022 | |
| Halozyme INC | $174.27 | 2023 | |
| Coloplast Corp | $172.55 | 2019-2021 | |
| Endo Pharmaceuticals INC. | $167.85 | 2019-2023 | Xiaflex |
| Boston Scientific Corporation | $134.36 | 2020-2025 | Axonics |
| Dendreon Pharmaceuticals LLC | $126.16 | 2019-2023 | Provenge |
| Tempus Ai, INC | $103.91 | 2024-2025 | Xt Cdx |
| Axonics, INC. | $64.21 | 2020-2021 |
Show all 28 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Vertex Pharmaceuticals Incorporated | $56.00 | 2025 | |
| Janssen Biotech, INC. | $49.51 | 2019-2025 | Erleada |
| 180 Medical, INC. | $47.99 | 2022 | |
| Allergan, INC. | $45.07 | 2020-2021 | |
| Tolmar Pharmaceuticals, INC. | $44.34 | 2021-2022 | |
| Laborie Medical Technologies Corp. | $40.95 | 2023-2024 | Optilume Bph Drug Coated Balloon Catheter |
| Myriad Genetic Laboratories, INC. | $24.61 | 2025 | Prolaris |
| Telix Pharmaceuticals | $21.76 | 2025 | Illuccix |
| Endo USA, INC. | $18.16 | 2025 | Aveed, Xiaflex |
| Amgen INC. | $17.43 | 2022 | |
| Hollister Incorporated | $16.22 | 2024 | Vapro Pocket |
| Abc Home Medical Supply, INC. | $16.22 | 2024 | |
| Merck Sharp & Dohme LLC | $13.98 | 2020 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Matthias Solga listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.